Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2011-005717-36Phase 3Terminated
Phase 3, randomised, double-blind trial of oxygen in preterm birth and hypopnea (2 arms), sponsored by Health Research Institute Hospital La Fe. Primary endpoint: Survival without bronchopulmonary dysplasia. Started Mar 2012; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2011-005717-36.